ClinicalTrials.gg
Enrolling by invitationNCT03300141Updated Oct 24, 2024

Looking Glass: Bimanual Balanced Reaching With Visual Biofeedback

An interventional study of Veridical Visual Feedback and Augmented Visual Feedback in Stroke, Stroke, Acute and Healthy, sponsored by Shirley Ryan AbilityLab. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-10-24.

Sponsored by Shirley Ryan AbilityLab · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 64 studies in Stroke by Shirley Ryan AbilityLab — 12 open to participants now, 20 under way, none of them phase 3. Stroke · Shirley Ryan AbilityLab.

Planned enrollment
10th of 55
75 · median 30
Started
2017
with 5 others
No phase
49 of 64
10 open now
Primary completion
2026-12
later than 9 of 19 live
Registered
24th of 64
by date

Among the 64 studies in Stroke by Shirley Ryan AbilityLab, this one is the 10th largest by planned enrollment of the 55 interventional ones that give a count, is one of 6 that started in 2017, is one of 49 with no phase, reaches primary completion later than 9 of the 19 other live ones, and was the 24th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

12 of the 64 studies in Stroke by Shirley Ryan AbilityLab are open now, in 1 country. Recruiting first, the newest first:

6 more — sign in →

By country, each count listing its studies:

All 12 open studies →

Where they have run

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 64 studies in Stroke by Shirley Ryan AbilityLab, or all of them as a file.
02

Study summary

The goal of this research study is to increase understanding of error augmentation by applying it to visual feedback during motion tracking with a Leap Motion device - a recently developed optical hand tracking tool - and the LookingGlass - a new, portable virtual reality environment.

In conjunction with the Leap, large, three dimensional work spaces can provide an immersive and virtual augmented environment for rehabilitation. Previously, experiments have utilized the Virtual Reality Robotic and Optical Operations Machine (VRROOM) to create such visually immersive environments. The Robotics lab as part of the Arms and Hands Lab on the 22nd floor of the Shirley Ryan Abilitylab has developed a portable version of this system, which is more compact and clinic-compatible. Combining this visual 3D system with the Leap creates a novel, more capable apparatus for studying error augmentation.

This research study will have 3 different arms: 1.) a healthy group of individuals (Healthy Arm), 2.) a group of stroke survivors within 8 months of stroke (Acute Arm), and 3.) a group of stroke survivors that had their stroke more than 8 months ago (Chronic Arm).

Each Arm will use the Leap motion tracker and the Looking Glass to participate in a reaching intervention. The healthy arm will only participate in 1 visit with an intervention with and without error augmented visual feedback. The Acute Arm and the Chronic Arm will both have 2 groups: 1.) Error Augmented Visual Feedback group and 2.) Non-Augmented or Veridical Visual Feedback group.

The Chronic Arm will have a structured intervention and evaluation protocol: Study staff will administer outcome assessments at 3 time points: a.) prior to intervention, b.) post intervention, and c.) 2 months after the conclusion of intervention. Intervention will occur over the span of 6-8 weeks with the goal of 3 1-hour sessions per week.

The Acute Arm will have a less structured intervention that will occur while the participant is an inpatient at Shirley Ryan AbilityLab. Study staff will administer outcome assessments at at least 2 time points: a.) prior to intervention, b.) post intervention just prior to discharge from Shirley Ryan AbilityLab. Between initial and post intervention evaluations, midpoint evaluations will take place at a maximum of once per week if the participant's schedule, activity tolerance, and length of stay allows. Intervention will consist of 1-hour sessions occurring according to the availability of the participant at the rate of no more than 2 sessions in a 24 hour period.

Investigators hope to investigate these questions:

  1. Can the movement of healthy individuals be characterized with error augmented visual feedback and veridical visual feedback?
  2. Will error augmented visual feedback or veridical visual feedback result in greater movement ability improvement?

    Investigators hypothesize that in the Chronic Arm, those what trained with error-augmented visual feedback will have improved movement ability compared to those who trained with veridical visual feedback.

  3. Is treatment with the looking glass and leap system feasible with an inpatient population?

Investigators hypothesize that this treatment will be feasible for an inpatient population.

03

Conditions studied

  • Stroke
  • Stroke, Acute
  • Healthy

Browse trials for

Keywords

  • Upper Extremity
  • Rehabilitation
  • Arm
  • Robotics
  • Stroke Rehabilitation
  • Virtual Reality Thearpy
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 8 months post stroke
  • FMUE 15-50
  • Active shoulder and elbow flexion-extension when supported against gravity to accomplish a forward mediolateral and inferior-superior reaching movements of 30 cm

Exclusion criteria

Exclusion Criteria:

  • Bilateral paresis
  • Severe sensory deficits in the affected limb
  • Severe spasticity preventing movement (MAS 4 or greater at elbow)
  • Aphasia, cognitive impairment or affective dysfunction that influence ability to participate in the experiment
  • Inability to provide
  • Severe current medical problems
  • Diffuse/multiple lesion sites or multiple strokes
  • Hemi-spatial neglect or visual field cut preventing subjects from seeing the target
  • Inability to maintain the testing positions
  • Botox injections in the affected Upper Extremity within the past 4 months
  • Concurrent participation in Upper Extremity rehab (research or prescribed therapy)
  • Participation in previous, similar robotics intervention studies
  • Pregnant women, children and teenagers, prisoners
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
75 participants (estimated)

Study arms

  • Active comparator
    Healthy

    Healthy participants will participate in reaching activity using the Looking Glass and Leap motion tracking system

    Other: Healthy Comparative Reaching Task

  • Experimental
    Chronic Veridical Visual Feedback

    Reaching while sitting at the Looking Glass system. The representation of arm movements will directly reflect the participants actual arm movements.

    Other: Veridical Visual Feedback

  • Experimental
    Chronic Augmented Visual Feedback

    Reaching while sitting at the Looking Glass system. The representation of a participant's arm movements will be augmented to encourage different movement patterns and improved movement.

    Other: Augmented Visual Feedback

  • Experimental
    Acute Veridical Visual Feedback

    Reaching while sitting at the Looking Glass system. The representation of arm movements will directly reflect the participants actual arm movements.

    Other: Veridical Visual Feedback

  • Experimental
    Acute Augmented Visual Feedback

    Reaching while sitting at the Looking Glass system. The representation of a participant's arm movements will be augmented to encourage different movement patterns and improved movement.

    Other: Augmented Visual Feedback

Interventions

  • OtherVeridical Visual Feedback

    Reaching while sitting at the Looking Glass system. The representation of arm movements will directly reflect the participants actual arm movements.

    Also known as: Reaching

  • OtherAugmented Visual Feedback

    Reaching while sitting at the Looking Glass system. The representation of a participant's arm movements will be augmented to encourage different movement patterns and improved movement.

    Also known as: Reaching, Error Augmentation

  • OtherHealthy Comparative Reaching Task

    Reaching while sitting at the Looking Glass system. This will occur over the course of 1 hour.

    Also known as: Healthy Reaching

06

What researchers measure

Primary outcomes

  1. Fugl Meyer Upper Extremity Score: Pre to Post/Discharge - Chronic and Acute Arms

    Change in Fugl Meyer score from pre-evaluation to post -evaluation

    Time frame: 1-3 weeks for acute arm; 9 weeks for chronic arm

Secondary outcomes

  1. Fugl Meyer Upper Extremity Score: Pre to Follow-up

    Change in Fugl Meyer score from pre-evaluation to follow-up-evaluation - Chronic Arm

    Time frame: 4.5 months

  2. Amount of use

    Time spent in treatment - Acute Arm

    Time frame: 1-3 weeks, on average

  3. Action Research Arm Test Score: Pre to Post

    Change in Action Research Arm Test score from pre-evaluation to post -evaluation: Chronic and Acute Arms

    Time frame: 1-3 weeks for acute arm; 9 weeks for chronic arm

  4. Action Research Arm Test Score: Pre to Follow-Up

    Change in Action Research Arm Test score from pre-evaluation to Follow-up -evaluation: Chronic Arm

    Time frame: 4.5 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2017 (actual). Primary completion is estimated for Dec 2026, 112 months after the start.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 112 months is above that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 13, 2017
First posted
Oct 3, 2017
StartActual
Aug 8, 2017
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Oct 24, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 24, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03300141
Responsible party
James Lanphier Patton (Co-Director, Robotics Laboratory, Arms and Hands Lab, Shirley Ryan AbilityLab, Shirley Ryan AbilityLab) — Principal investigator
First posted
Oct 3, 2017
Start date
Aug 8, 2017
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Oct 24, 2024

Study contacts

James Patton
principal investigator · Shirley Ryan AbilityLab and University of Illinois at Chicago (UIC)

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion